The GLP is committed to full transparency. Download and review our 2019 Annual Report

Facing 10,000 plus glyphosate-cancer lawsuits, Bayer enters court-ordered mediation with next plaintiff

| | April 15, 2019
Monsanto Bayer x
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer said on [April 12] it would comply with a U.S. federal judge’s order to enter mediation with a plaintiff who claims the company failed to warn against an alleged cancer risk from its Roundup weedkiller.

Related article:  'We need it now': Why precision medicine isn't doing enough for children with cancer

Bayer has seen billions wiped off its market value since August, when a first U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of the alleged risk from Roundup, which is based on active ingredient glyphosate.

It suffered a similar courtroom defeat [in March]  and more than 10,000 cases are pending.

U.S. District Judge Vince Chhabria….said in a filing dated [April 11] that Bayer and another plaintiff, Elaine Stevick, were ordered to start confidential mediation.

Read full, original article: Bayer says to comply with court mediation order in glyphosate case

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend